CD33 and breast carcinoma: In our previous study, we identified a subset of immature MDSCs in human breast cancer tissues with the phenotype of Lin−HLA−DR−CD45+CD33+CD13+CD14−CD15− that exerted potent immunosuppressive effects on T cells in vitro and in vivo (7).